Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Oncol Rep ; 20(3): 657-62, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18695920

ABSTRACT

Normal breast development is controlled by a balance between cell proliferation and apoptosis. The balance between the two parameters is crucial for determining the growth or regression of breast tumours in response to therapies and treatments. Therefore, it is necessary to understand the role of apoptosis in tumour progression. Active caspases participate as essential elements in the execution of apoptotic mechanisms. In the present study, we analysed the activities of caspase-3, -8 and -9 as well as cytochrome c release in N-methyl-nitrosourea (NMU)-induced rat mammary tumours, in order to establish the apoptotic events that occur in tumour growth in this animal model. Forty female virgin Wistar rats were randomly divided into two groups. One group was injected intraperitoneally with three doses of 50 mg/kg body weight of NMU. The control group received the vehicle only. After 122 days of NMU injection, the rats were sacrificed and the tumours were excised and processed. Results showed that in mammary tumours induced by NMU, the apoptotic death receptor-mediated pathway is activated through caspase-3 and -8, but the apoptotic mitochondrial pathway is suppressed through a non-activating process of caspase-9 activity, despite the release of cytochrome c. In conclusion, these findings have demonstrated a suppression of the apoptotic mitochondrial pathway through a non-activating process of caspase-9 activity, despite the release of cytochrome c in mammary tumours induced by NMU. Although the apoptotic death receptor-mediated pathway is activated, it is not enough to maintain the balance between proliferation and apoptosis, and thus determine the overall growth of the tumour.


Subject(s)
Alkylating Agents/toxicity , Apoptosis/physiology , Caspase 3/metabolism , Caspase 8/metabolism , Caspase 9/metabolism , Mammary Neoplasms, Animal/enzymology , Methylnitrosourea/toxicity , Animals , Apoptosis/drug effects , Breast Neoplasms/metabolism , Cytochromes c/metabolism , Female , Mammary Neoplasms, Animal/chemically induced , Mammary Neoplasms, Animal/pathology , Mitochondria/metabolism , Rats , Rats, Wistar , Tumor Cells, Cultured
2.
Toxicol Lett ; 169(3): 236-44, 2007 Mar 30.
Article in English | MEDLINE | ID: mdl-17337135

ABSTRACT

Several reports have recently described that acrylonitrile (ACN) toxicity resides in its capacity for inducing oxidative stress. ACN can be conjugated with glutathione (GSH), diminishing its cellular content, or being metabolized to cyanide. In the present report, we determine the effect of ACN on the viability of primary-cultured astrocytes as well as the oxidative damage generated by ACN by measuring GSH levels in primary cultured astrocytes. We also analyzed whether the ACN (2.5mM) toxicity could be avoided by using antioxidants such as taurine (5mM), N-acetylcysteine (20 mM), trolox (100 microM), estradiol (10 microM) and melatonin (100 nM-1mM). In this cell culture model, antioxidants were not able to prevent ACN-induced cell damage, with the exception of NAC, confirming that only GSH seems to play a key role in ACN-derived toxicity. Additionally, we measured different parameters of oxidative stress such as catalase activity, lipid peroxidation and GSH concentration, as indicators of the potential oxidative stress mediated by the toxicity of ACN, after exposure of Wistar rats to a concentration of 200 ppm ACN for 14 days. At the concentration assayed, we did not find any evidence of oxidative damage in the brain of ACN-treated rats.


Subject(s)
Acrylonitrile/toxicity , Antioxidants/pharmacology , Astrocytes/drug effects , Oxidative Stress/drug effects , Animals , Astrocytes/enzymology , Astrocytes/metabolism , Body Weight/drug effects , Catalase/metabolism , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Glutathione/metabolism , Lipid Peroxidation/drug effects , Male , Rats , Rats, Wistar
3.
Neuropeptides ; 39(2): 67-72, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15752539

ABSTRACT

In developing cerebellum, where critical periods of vulnerability have been established for several basic substances, it has been extensively studied the wide array of abnormalities induced by exposure to ethanol (EtOH). However, little is known about the effects of EtOH consumption on cerebellar functions in adult individuals. Several studies show participation in cognitive activities to be concentrated in the lateral cerebellum (hemispheres), whereas basic motor functions such as balance and coordination are represented in the medial parts of the cerebellum (vermis and paravermis). In addition to the circulating renin angiotensin system (RAS), a local system has been postulated in brain. The effector peptides of the RAS are formed via the activity of several aminopeptidases (AP). The present work analyses the effect of chronic EtOH intake on the RAS-regulating AP activities in the soluble and membrane-bound fractions of two cerebellar locations: the hemispheres and the vermis. We hypothesize that cerebellar RAS is involved in basic motor functions rather than in cognitive activities.


Subject(s)
Aminopeptidases/metabolism , Cerebellum/drug effects , Cerebellum/enzymology , Ethanol/administration & dosage , Renin-Angiotensin System/physiology , Animals , Cell Membrane/enzymology , Glutamyl Aminopeptidase/metabolism , Male , Mice , Mice, Inbred BALB C , Motor Activity/physiology
4.
Life Sci ; 75(11): 1369-77, 2004 Jul 30.
Article in English | MEDLINE | ID: mdl-15234194

ABSTRACT

Oxytocinase has been reported to hydrolyse the peptide hormone oxytocin (OT). We have previously described changes in oxytocinase activity in human breast cancer, where a highly significant increase occurred in tumoral tissue. In the present work, we analysed oxytocinase activity in serum of rats with breast cancer induced by N-methyl-nitrosourea (NMU). We also correlated these data with the number and size of tumors and the body weight of the animals to evaluate the putative value of this activity as a biological marker of the disease. Our results confirm the involvement of OT in carcinogenesis and suggest a mayor role for oxytocinase activity in the development of breast cancer.


Subject(s)
Cystinyl Aminopeptidase/blood , Mammary Neoplasms, Experimental/enzymology , Animals , Body Weight/drug effects , Carcinogens , Disease Models, Animal , Female , Mammary Neoplasms, Experimental/pathology , Methylnitrosourea , Rats , Rats, Wistar
5.
Rev Neurol ; 35(8): 784-93, 2002.
Article in Spanish | MEDLINE | ID: mdl-12402234

ABSTRACT

In the present review, the characteristics of mammalian neuropeptides have been studied. Neuropeptides are widely distributed not only in the nervous system but also in the periphery. They are synthesised by neurons as large precursor molecules (pre propeptides) which have to be cleaved and modified in order to form the mature neuropeptides. Neuropeptides may exert actions as neurotransmitters, neuromodulators and/or neurohormones. In the neurons, they coexist with classic transmitters and often with other peptides. After their releasing, they bind to especific receptors to exert their action in the target cell. Most of these receptors belongs to a family of G protein coupled receptors. Finally, peptidases are the enzymes involved in the degradation of neuropeptides. Conclusions. In the last years, the number of known neuropeptides and the understanding of their functions have been increased. With these data, present investigations are looking for the treatment of different pathologies associated with alterations in the physiology of neuropeptides.


Subject(s)
Neuropeptides/physiology , Animals , Feeding Behavior/physiology , GTP-Binding Proteins/physiology , Humans , Immune System/physiology , Nerve Tissue Proteins/physiology , Neurotransmitter Agents/physiology , Pain/physiopathology , Peptide Hydrolases/physiology , Protein Precursors/metabolism , Receptors, Neuropeptide/physiology , Reproduction/physiology , Signal Transduction , Synapses/physiology , Water-Electrolyte Balance/physiology
6.
Exp Gerontol ; 47(8): 625-30, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22664577

ABSTRACT

It is well known that oxidative stress is one of the earliest events in Alzheimer's disease pathogenesis, indicating that may play a key role in this disease. In our study, we measured the levels of oxidative stress indicators (TBARS and protein carbonyls content) and the non-enzymatic (glutathione (GSH) and oxidized glutathione (GSSG)) and enzymatic (glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD)) defense systems in the plasma of 46 patients diagnosed of ATD and 46 age-matched controls. We found decreased levels in total GSH in ATD patients, although healthy control women showed lower levels of total GSH than healthy control men. On the contrary, we found increased levels of TBARS and carbonyl groups content in ATD patients in both genders. The activity of the plasma antioxidant enzymes showed no changes for SOD activity in ATD patients, independently of the gender, although western blot analysis showed an increase in SOD-1 protein. CAT activity was also decreased in ATD patients, although this decrease is mainly due to the decrease found in men but not in women. However, western blot analysis did not show differences in CAT protein between controls and ATD patients. Finally, a decrease of GPx activity was found in ATD patients in both genders. However, as with CAT protein, western blot analysis did not show differences in GPx protein between controls and ATD patients. Our results suggest that there is a defect in the antioxidant defense system that is incapable of responding to increased free radical production, which may lead to oxidative damage and the development of the pathological alterations that characterize the neurodegenerative disorder of patients with ATD. Thus, oxidative damage could be one important aspect for the onset of ATD and oxidative stress markers could be useful to diagnose the illness in their earliest stages through both non-invasive, reliable and cost-affordable methods.


Subject(s)
Alzheimer Disease/diagnosis , Biomarkers/blood , Oxidative Stress/physiology , Aged , Alzheimer Disease/blood , Alzheimer Disease/physiopathology , Case-Control Studies , Catalase/blood , Early Diagnosis , Female , Glutathione/blood , Glutathione Peroxidase/blood , Humans , Lipid Peroxidation/physiology , Male , Neuropsychological Tests , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/analysis
7.
J Insect Physiol ; 56(11): 1665-70, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20615411

ABSTRACT

The division of labor between the different worker castes of leaf-cutting ants may reflect in their capacity to exchange liquids by trophallaxis. The crop capacity of and trophallactic exchanges between different size classes of worker leaf-cutting ants of the sub-species Acromyrmex subterraneus subterraneus were investigated. Size classes were defined from head capsule widths and crop capacity of each class was determined following ad libitum feeding on dye solution. Experiments were carried out to investigate trophallactic exchanges between donor ants and recipient ants of each class size combination on a one to one basis. An experiment was also performed to investigate dye distribution within mini-colonies following introduction of three classes of donor ants. Worker ants were categorized into four size classes from their head capsule widths (C1=0.8-1.0 mm; C2=1.2-1.5 mm; C3=1.6-2.0 mm; C4=2.1-2.4 mm). C1 ants crop capacity was 0.13 microL; C2: 0.21 microL; C3: 0.52 microL; C4: 1.03 microL. Ants of each class previously fed on the dye solution (donors) were placed individually with an unfed ant of each class (recipients) and the presence of dye solution, passed from the donor to the recipient by oral trophallaxis was observed after 1h. Results showed that all classes of donor ants performed trophallactic exchanges with all recipient classes. However, statistically fewer exchanges were seen for C2 donor ants when placed with C3 recipient ants. Ten donor ants of each of three classes (C2, C3 and C4) were introduced into mini-colonies without queen ants. It was observed that C1 and C2 ants were poor recipients, whilst C3 and C4 received the highest percentages of dye. Within 10h of introducing the donor ants, 14 to 20% of their nest-mates had received dye solution, with 58 to 77% of dye passed to recipients. These studies show the altruistic nature of "food-laden" leaf-cutters and indicate that ants involved in garden maintenance activity are less likely to receive liquids from foraging workers.


Subject(s)
Ants/physiology , Body Size/physiology , Feeding Behavior/physiology , Animals , Energy Metabolism , Evans Blue , Social Behavior
8.
Anticancer Agents Med Chem ; 9(5): 500-16, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19519292

ABSTRACT

It is well known that cancer is defined as a group of diseases that differ both regarding the tissues they affect as well as their origin. For this reason, much effort is being made in the development of new drugs with the aim of increasing survival and patients' quality of life. There is already a wide spectrum of anti-cancer agents that follow different mechanisms of action, such as the inhibitors of topoisomerases I and II and anti-mitotic chemicals, among others. Usually, these drugs are able to increase the patient's survival, although their toxicity worsens the patient's quality of life. Therefore, we should seriously consider alternative mechanisms, as well as the co-administration of these drugs with non-toxic compounds, such as melatonin or retinoic acid. This would increase the toxic effects of these drugs at low doses. Obviously, a better understanding of modified physiological systems during the development of these diseases would improve the diagnostic tools. This would be translated, in turn, into a higher survival index. The alteration of the proteolytic enzymes involved in the renin-angiotensin system and in the regulation of the gonadotrophins and TRH synthesis in breast cancer are examples of the above. These two proteins are regulated by the same enzyme, pyrrolidon carboxipeptidase, and both are directly involved in the initiation and development of breast cancer. Therefore, the aim of the present review is to revise the different options available at present to improve patients' survival and to show alternative mechanisms that may be beneficial to patients' well being.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/metabolism , Neoplasms/drug therapy , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents, Hormonal/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Biomarkers, Tumor/genetics , Humans , Renin-Angiotensin System
9.
Cancer Invest ; 24(2): 149-53, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16537183

ABSTRACT

OBJECTIVE: Pineal function has been considered particularly as a neuroendocrine modulator in hormone responsive tumors, like the hormone-dependent mammary tumors. The complexity of the gland function, moreover, is denoted by the presence of a local renin-angiotensin-system (RAS) that regulates melatonin biosynthesis. Classically, angiotensin II (Ang II) has been considered as the effector peptide of the RAS, but Ang II is not the only active peptide. Several of its degradation products, including angiotensin III (Ang III) and angiotensin IV (Ang IV) also possess biological functions. These peptides are formed via the activity of several aminopeptidases. Our aim is to know their role in the regulation of pineal RAS and breast cancer. DESIGN: Aminopeptidase N (APN), aminopeptidase B (APB) and aminopeptidase A (aspartyl- and glutamyl-aminopeptidase, APA) activities are measured in the pineal gland of rats with breast cancer induced by N-methyl nitrosourea (NMU). METHODS: Aminopeptidase activities were measured fluorimetrically using their corresponding aminoacyl-beta-naphthylamides as substrates. RESULTS: Specific APN and APB activities in pineal gland of controls and NMU-treated rats were not modified. Aspartyl aminopeptidase activity significantly decreased in NMU-treated rats when compared with control group. On the contrary, glutamyl aminopeptidase activity did not show significant differences between groups. CONCLUSIONS: We propose that the local RAS in pineal gland is modified in rats with breast cancer induced by NMU through the inhibition of AspAP activity, which may lead to increased levels of Ang II. Ang II could be responsible of the overproduction of melatonin, supporting a mechanism to restrain the promotion and/or progression of breast cancer.


Subject(s)
Aminopeptidases/metabolism , Mammary Neoplasms, Experimental/enzymology , Pineal Gland/enzymology , Renin-Angiotensin System/physiology , Alkylating Agents/toxicity , Angiotensin II/metabolism , Animals , Female , Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/physiopathology , Melatonin/metabolism , Methylnitrosourea/toxicity , Rats
10.
Gen Comp Endocrinol ; 141(2): 135-40, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15748714

ABSTRACT

Opioids are involved in the regulation of hypothalamus-pituitary-adrenal (HPA) axis activity under physiological conditions. In the present work, we analyzed the influence of ovariectomy and estradiol (E), progesterone (P) or estradiol plus progesterone (E+P) replacement on soluble (S) and membrane-bound (MB) enkephalin-degrading aminopeptidase activity (EDA) in the HPA axis. Female mice (Balb/C) were distributed in 15 groups of 10 animals each: sham-operated controls (C), ovariectomized controls (OV-C), and ovariectomized mice treated with increasing doses of E (10, 20 or 40 mg/kg), P (100, 200 or 400 mg/kg) or E+P (10+100, 20+200 or 40+400 mg/kg). In hypothalamus, ovariectomy increased both S and MB EDA activities, whereas E replacement returned them to control levels, although MB EDA activity increased again after the replacement with 40 mg/kg E. P replacement increased S EDA activity, but returned MB EDA activity to control levels. The replacement of E+P returned both S and MB EDA activities to control levels, although MB EDA activity was lower than control values after the replacement with 10+100 mg/kg E+P. In pituitary, neither ovariectomy nor the replacement of E or E+P changed S EDA, although the highest concentrations of P increased S EDA activity. However, ovariectomy increased MB EDA and E replacement returned the activity to control or below control levels, depending on the concentration used. However, P administration returned the activity to control or below control levels depending on the concentration used, although 200 mg/kg P had no effects on MB EDA. E+P replacement returned pituitary MB EDA activity to control levels. In adrenal glands, ovariectomy did change either S or MB EDA. However, E, P or E+P replacement decreased S EDA activity in different degrees, depending of the dose administrated. No changes were detected in MB EDA after hormone replacement. These results indicate that female steroid hormones influence EDA activity at different levels of HPA axis.


Subject(s)
Aminopeptidases/metabolism , Estrogens/pharmacology , Hypothalamo-Hypophyseal System/enzymology , Pituitary-Adrenal System/enzymology , Progesterone/pharmacology , Animals , Estrogen Replacement Therapy , Female , Hypothalamo-Hypophyseal System/drug effects , Mice , Mice, Inbred BALB C , Ovariectomy , Pituitary-Adrenal System/drug effects , Stress, Physiological/metabolism
11.
Horm Metab Res ; 37(2): 74-8, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15778922

ABSTRACT

Pyrrolidon carboxypeptidase is an omega-peptidase that hydrolyses N-terminal pyroglutamyl residues from biologically active peptides such as gonadotropin-releasing and thyrotrophin-releasing hormones. We previously described a decrease in both rat and human pyrrolidon carboxypeptidase activity with breast cancer, suggesting that gonadotropin-releasing hormone may be an important local intracrine, autocrine and/or paracrine hormonal factor in the pathogenesis of breast cancer while playing a role in the tumoral process. However, the other susceptible substrate of pyrrolidon carboxypeptidase, thyrotrophin-releasing hormone, may also be modified with breast cancer, supporting an association between breast cancer and thyroid disorders. The present work analyses soluble and membrane-bound pyrrolidon carboxypeptidase activities in the hypothalamus-pituitary-thyroid and hypothalamus-pituitary-ovary axes in N-methyl nitrosourea-induced breast cancer in rats. Our aim was to determine the possible relationship between gonadotropin-releasing hormone and thyrotrophin-releasing hormone regulation through pyrrolidon carboxypeptidase activity. We propose that pyrrolidon carboxypeptidase activity dysregulation at various local and systemic levels may participate in the initiation, promotion and progression of breast cancer induced in rat by N-methyl nitrosourea through the increase in gonadotropin-releasing hormone. Since pyrrolidon carboxypeptidase activity also acts on thyrotrophin-releasing hormone, the dysregulation of this enzyme's activity could indirectly affect hypothalamus-pituitary-thyroid axis function, and thus potentially represent a link between the diseases of thyroid and breast cancer.


Subject(s)
Carboxypeptidases/metabolism , Endocrine Glands/metabolism , Hormones/metabolism , Mammary Neoplasms, Experimental/metabolism , Nitrosourea Compounds/toxicity , Animals , Female , Mammary Neoplasms, Experimental/chemically induced , Mammary Neoplasms, Experimental/complications , Rats , Rats, Wistar , Thyroid Diseases/etiology , Thyroid Diseases/metabolism
12.
Behav Neural Biol ; 58(1): 37-44, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1417669

ABSTRACT

This study was undertaken to examine (1) whether pre- and/or postoperative training, using water reinforcement, to turn in circles (rotation) affects the behavioral symptoms induced by unilateral 6-hydroxydopamine (6-OHDA)-induced DA denervation of the rat substantia nigra (SN); (2) whether there was any influence of this training on the temporal pattern of recovery; and (3) whether the rotational training influences turning induced by systemic injection of dopaminergic drugs. In the first experiment, rats were trained either ipsi- or contraversive (TI or TO) to the side to be damaged 11 days before and 23 days after lesion, and tested in an open field for rotational behavior following systemic administration of apomorphine and amphetamine. In the second experiment rats were trained only before the lesion was made and tested in the open field for spontaneous circling and thigmotactic behavior. The results of the first experiment indicated maintenance of the training performance after the lesion. At the 14th day after the lesion, the ipsiversive trained group showed a higher contraversive circling frequency after apomorphine injection in relation to the contralateral trained group. In the second experiment, rats trained only before the surgery, showed asymmetrical spontaneous circling in the trained direction before and 14 days after surgery, indicating, in a drug free condition, that training direction can be restored after unilateral SN lesions, even to the contralateral body side. Moreover, thigmotactic behavior indicated a lack of habituation in an open field in unilateral lesion rats.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Amphetamine , Apomorphine , Learning , Substantia Nigra/surgery , Animals , Habituation, Psychophysiologic , Humans , Injections, Intraperitoneal , Locomotion , Male , Rats , Research Design
13.
Gen Comp Endocrinol ; 134(3): 303-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14636637

ABSTRACT

Opiates are involved in the regulation of several functions in the hypothalamus-pituitary-adrenal (HPA) axis under physiological conditions. The aim of the present work is to study the influence of orchidectomy and testosterone (T) replacement on soluble (S) and membrane bound (MB) enkephalin-degrading aminopeptidase (EDA) activities in the HPA axis. Forty male mice (Balb/C) were distributed in five groups: sham-operated control (C), orchidectomized (OR-C), and orchidectomized treated with increasing doses of T (3, 6 or 12 mg/kg). In hypothalamus, orchidectomy did not modify either S or MB EDA, although T replacement increased S but not MB EDA. In pituitary, neither S nor MB EDA activities changed with orchidectomy, although both activities changed after T replacement. On the other hand, in adrenal glands, orchidectomy increased S and MB EDA activities, whereas T replacement returned both activities to control levels. These results suggest a direct effect of T in S and MB EDA activities and therefore, an influence on their endogenous substrates regulation.


Subject(s)
Aminopeptidases/pharmacology , Hypothalamo-Hypophyseal System/physiology , Orchiectomy/veterinary , Pituitary-Adrenal System/physiology , Testosterone/pharmacology , Animals , Cell Membrane , Male , Mice , Mice, Inbred BALB C , Solubility , Testosterone/administration & dosage
14.
Horm Metab Res ; 36(3): 131-5, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15057664

ABSTRACT

Pyrrolidone carboxypeptidase, also known as pyroglutamyl aminopeptidase, removes pyroglutamyl terminal residues from biologically active peptides such as thyrotropin-releasing hormone. The aim of the present work was to study the influence of orchidectomy and testosterone replacement on soluble (pyrrolidone carboxypeptidase type I) and membrane-bound (pyrrolidone carboxypeptidase type II) activities in the hypothalamus-pituitary-adrenal axis. Forty male mice (Balb/C) were distributed into five groups: sham-operated controls, orchidectomized, and orchidectomized treated with increasing doses of testosterone in each group (3, 6 and 12 mg/kg). In the hypothalamus, orchidectomy increased pyrrolidone carboxypeptidase type I, whereas the highest dose of testosterone returned this activity to control levels. In the pituitary, neither pyrrolidone carboxypeptidase type I nor type II activities changed after orchidectomy, although both activities increased after administration of testosterone in both cases. On the other hand, orchidectomy increased pyrrolidone carboxypeptidase type I and type II activities in adrenal glands, while testosterone replacement returned it to control levels. These results suggest that testosterone differentially modulates pyrrolidone carboxypeptidase type I and type II activities, and therefore also their endogenous substrate regulation. Thus, the influence of sex hormones in the physiology of the HPA axis through the modulation of the Pyrrolidone carboxypeptidase type I and type II activities is of great importance on stress and neuropathology associated with HPA dysfunction


Subject(s)
Androgens/pharmacology , Hypothalamo-Hypophyseal System/enzymology , Orchiectomy , Pituitary-Adrenal System/enzymology , Pyroglutamyl-Peptidase I/metabolism , Testosterone/pharmacology , Androgens/administration & dosage , Animals , Dose-Response Relationship, Drug , Hypothalamo-Hypophyseal System/drug effects , Male , Mice , Mice, Inbred BALB C , Pituitary-Adrenal System/drug effects , Testosterone/administration & dosage
15.
Horm Metab Res ; 34(8): 431-4, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12198597

ABSTRACT

Pyroglutamyl aminopeptidase (pGluAP) is an omega peptidase that hydrolyzes biologically active peptides, such as thyrotropin-releasing hormone (TRH), with neuronal and extraendocrine functions. We analyzed the effects of a cholesterol-enriched diet on soluble and membrane-bound pGluAP activity in frontal cortex, pituitary and adrenal glands of male and female mice using fluorimetric assays. Significant increases were observed in soluble pGluAP activity in the frontal cortex and adrenal glands in males and in the pituitary in females. Membrane-bound pGluAP activity was increased in the frontal cortex and pituitary of males and females after the mice were fed a cholesterol-enriched diet. These increases may produce changes in the metabolism of endogenous substrates, including TRH, which may be related to alterations in its neuromodulator functions and to the possible relationship between TRH and other neurotransmitter systems.


Subject(s)
Adrenal Glands/enzymology , Aminopeptidases/metabolism , Cholesterol, Dietary/pharmacology , Glutamine/analogs & derivatives , Pituitary Gland/enzymology , Prefrontal Cortex/enzymology , Adrenal Glands/drug effects , Aminopeptidases/physiology , Animals , Female , Fluorometry , Glutamine/metabolism , In Vitro Techniques , Male , Membranes/drug effects , Membranes/enzymology , Membranes/metabolism , Mice , Mice, Inbred BALB C , Naphthalenes/metabolism , Pituitary Gland/drug effects , Pyrrolidonecarboxylic Acid/analogs & derivatives , Sex Characteristics , Thyrotropin-Releasing Hormone/physiology
16.
Horm Metab Res ; 35(8): 502-5, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12953169

ABSTRACT

Pyrrolidone carboxypeptidase (Pcp) (E.C. 3.4.19.3) is an omega peptidase widely distributed in animal fluids and tissues and hydrolyses N-terminal pyroglutamic residues from biologically active peptides such as gonadotropin releasing hormone (GnRH). Previous results obtained by us showed a decrease in human breast cancer Pcp activity, suggesting that this enzyme activity or its putative substrates may play a major role in breast cancer pathogenesis. The aim of the present work is to analyse serum Pcp activity in N-methyl-nitrosourea (NMU) induced rat mammary tumours using pyroglutamyl-beta-naphthylamide as substrate. Serum Pcp activity was significantly lower in NMU-treated rats than in controls. Moreover, multiple regression analysis showed a significant correlation between Pcp activity and the number and size of tumours and the body weight of the animals. Since NMU-induced carcinomas are mainly oestrogen-dependent, the decrease observed in Pcp activity may reflect an increase in circulating levels of GnRH that lead to an increase in gonadal steroid hormones production responsible, at least in part, for the initiation and promotion of the disease.


Subject(s)
Breast Neoplasms/enzymology , Pyroglutamyl-Peptidase I/blood , Animals , Biomarkers, Tumor/analysis , Body Weight , Breast Neoplasms/blood , Breast Neoplasms/chemically induced , Breast Neoplasms/pathology , Carcinogens , Female , Methylnitrosourea , Rats , Rats, Wistar , Regression Analysis
17.
Psiquiatr. biol ; Psiquiatr. biol;5(1): 23-32, mar. 1997. tab, graf
Article in Portuguese | LILACS | ID: lil-187231

ABSTRACT

O presente estudo investigou o efeito dos tratamentos crônicos com L-DOPA e MK-801 no desenvolvimento do processo de supersensibilidade dopaminérgica, utilizando um modelo de hemiparkinsonismo. Rotaçoes contralaterais à lesao foram utilizadas como medida comportamental do processo de supersensibilidade. Ratos lesados unilateralmente com 6-OHDA na substância negra foram tratados sistemicamente com L-DOPA/carbidopa e MK-801 durante 13 dias consecutivos, seguidos por um período de retirada de droga de 10 dias. Após esse período, os animais foram testados com salina e no dia seguinte testados com L-DOPA. Resultados mostraram que o tratamento com L-DOPA e o pré-tratamento com MK-801 nao impediram o aparecimento do processo de supersensibilidade, mas retardaram o início do mesmo. Entretanto, uma vez iniciado, o processo se tornou mais acentuado, visto que, após um período de retirada, a administraçao de L-DOPA produziu rotaçoes contralaterais equivalentes àquelas do 13§ dia. O grupo pré-tratado com MK-801, entretanto, apresentou um número de rotaçoes contralaterais semelhante ao apresentado pelo grupo salina. Ensaios bioquímicos utilizando a técnica de cromatografia líquida de alta eficiência (HPLC-EC) indicaram que o tratamento com L-DOPA nao produziu mudanças nos níveis dopaminérgicos estriatais. Entretanto, as razoes dopaminérgicas DOPAC/DA e HVA/DA dos grupos tratados com L-DOPA se encontravam aumentadas. Houve aumento nos níveis dopaminérgicos corticais. Em conclusao, o presente trabalho sugere que a administraçao crônica de L-DOPA nao é suficiente para impedir o desenvolvimento do processo de supersensibilidade, porém retarda o aparecimento deste. O pré-tratamento com MK-801, além de retardo, produz também a atenuaçao do processo.


Subject(s)
Animals , Male , Rats , Antiparkinson Agents/pharmacology , Dizocilpine Maleate/pharmacology , Levodopa/pharmacology , Neuroprotective Agents/pharmacology , Analysis of Variance , Antiparkinson Agents/therapeutic use , Carbidopa/pharmacology , Chromatography, Liquid , Disease Models, Animal , Dizocilpine Maleate/therapeutic use , Parkinson Disease/drug therapy , Hypersensitivity , Levodopa/therapeutic use , Neuroprotective Agents/therapeutic use , Postoperative Period , Rats, Sprague-Dawley , Receptors, Dopamine , Rotation
SELECTION OF CITATIONS
SEARCH DETAIL